Search Login Register

Hyperglobulinemic Purpura Summary

Description: Purplish or brownish red discoloration of the skin associated with increase in circulating polyclonal globulins, usually GAMMA-GLOBULINS. This syndrome often occurs on the legs of women aged 20 to 40 years.

Also Known As: Purpura, Hyperglobulinemic; Benign Hyperglobulinemic Purpura of Waldenström; Hypergammaglobulinemic Purpura of Waldenstrom; Hyperglobulinemic Purpura of Waldenström; Waldenstrom Hyperglobulinemic Purpura Show All >>

Networked: 15 relevant articles (0 outcomes, 0 trials/studies) for this Disease

Key Drugs and Agents for Hyperglobulinemic Purpura

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Antigen-Antibody Complex (Immune Complex) : 2 results : IBA
  2. Cytostatic Agents : 1 result : IBA
  3. Thioguanine (Tioguanine) : 1 result : FDA 1
  4. Rose Bengal : 1 result : IBA
  5. Prednisone (Sone) : 1 result : FDA 119 Generic
  6. Phenylbutazone (Butazolidin) : 1 result : FDA 11
  7. Macroglobulins : 1 result : IBA
  8. Immunoglobulin A (IgA) : 1 result : IBA
  9. Ethamsylate (Etamsylate) : 1 result : IBA
  10. Erythema elevatum diutinum : 1 result : IBA
Show All >>

Diseases Related to Hyperglobulinemic Purpura

  1. Polymyositis
  2. Vasculitis (Vasculitides)
  3. Sjogren's Syndrome (Sjogren Syndrome)
  4. Infection
  5. Hypergammaglobulinemia (Hyperimmunoglobulinemia)
Show All >>

Key Therapies for Hyperglobulinemic Purpura

Efficacy Chart >>
  1. Plasmapheresis : 1 result

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.